BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 2853597)

  • 1. Advances in functional lipid nanoparticles: from drug delivery platforms to clinical applications.
    Dhayalan M; Wang W; Riyaz SUM; Dinesh RA; Shanmugam J; Irudayaraj SS; Stalin A; Giri J; Mallik S; Hu R
    3 Biotech; 2024 Feb; 14(2):57. PubMed ID: 38298556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide functionalized liposomes for receptor targeted cancer therapy.
    Aronson MR; Medina SH; Mitchell MJ
    APL Bioeng; 2021 Mar; 5(1):011501. PubMed ID: 33532673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bombesin receptor-targeted liposomes for enhanced delivery to lung cancer cells.
    Akbar MJ; Lukasewicz Ferreira PC; Giorgetti M; Stokes L; Morris CJ
    Beilstein J Nanotechnol; 2019; 10():2553-2562. PubMed ID: 31921534
    [No Abstract]   [Full Text] [Related]  

  • 4. BN/GRP-like peptides and receptors in small cell lung cancer.
    Moody TW; Lebovic GS; Carney DN; Korman LY
    Int J Neurosci; 1988 May; 40(1-2):141-8. PubMed ID: 2840406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.
    Mahmoud S; Staley J; Taylor J; Bogden A; Moreau JP; Coy D; Avis I; Cuttitta F; Mulshine JL; Moody TW
    Cancer Res; 1991 Apr; 51(7):1798-802. PubMed ID: 1848479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High affinity receptors for bombesin/GRP-like peptides on human small cell lung cancer.
    Moody TW; Carney DN; Cuttitta F; Quattrocchi K; Minna JD
    Life Sci; 1985 Jul; 37(2):105-13. PubMed ID: 2409423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin inhibits the secretion of bombesin-like peptides from small cell lung cancer cells.
    Kee KA; Finan TM; Korman LY; Moody TW
    Peptides; 1988; 9 Suppl 1():257-61. PubMed ID: 2908812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance P analogues function as bombesin receptor antagonists and inhibit small cell lung cancer clonal growth.
    Bepler G; Zeymer U; Mahmoud S; Fiskum G; Palaszynski E; Rotsch M; Willey J; Koros A; Cuttitta F; Moody TW
    Peptides; 1988; 9(6):1367-72. PubMed ID: 2470067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The release of bombesin-like peptides from small cell lung cancer cells.
    Moody TW; Korman LY
    Ann N Y Acad Sci; 1988; 547():351-9. PubMed ID: 2853597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth factor and peptide receptors in small cell lung cancer.
    Moody TW; Cuttitta F
    Life Sci; 1993; 52(14):1161-73. PubMed ID: 8383784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptides as autocrine growth factors in cancer cells.
    Moody TW; Chan D; Fahrenkrug J; Jensen RT
    Curr Pharm Des; 2003; 9(6):495-509. PubMed ID: 12570813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide receptors as cancer drug targets.
    Moody TW
    Ann N Y Acad Sci; 2019 Nov; 1455(1):141-148. PubMed ID: 31074514
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.